Paul V. Maier, Director at Hana Biosciences Inc (HNAB), bought 7,000 shares at $0.75 ($5K) on 2008-06-18, disclosed to the SEC on 2008-06-18.
Open-market purchase of $5k HNAB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ETON | BUY | 2018-11-15 | $30K | — | Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |